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Abstract
Stimulation of neurons with brain-derived neurotrophic factor (BDNF) results in robust induction of SORLA, an intracellular
sorting receptor of the VPS10P domain receptor gene family. However, the relevance of SORLA for BDNF-induced neuronal
responses has not previously been investigated. We now demonstrate that SORLA is a sorting factor for the tropomyosin-
related kinase receptor B (TrkB) that facilitates trafficking of this BDNF receptor between synaptic plasma membranes, post-
synaptic densities, and cell soma, a step critical for neuronal signal transduction. Loss of SORLA expression results in
impaired neuritic transport of TrkB and in blunted response to BDNF in primary neurons; and it aggravates neuromotoric
deficits caused by low BDNF activity in a mouse model of Huntington’s disease. Thus, our studies revealed a key role for
SORLA in mediating BDNF trophic signaling by regulating the intracellular location of TrkB.
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Introduction
Sorting protein-related receptor containing LDLR class A
repeats (SORLA) is a member of the VPS10P domain receptor
gene family, a class of sorting proteins expressed in the
mammalian nervous system [1]. Typically, VPS10P domain
receptors shuttle between Golgi, plasma membrane, and early
endosome and direct intracellular trafficking of target proteins to
distinct subcellular compartments in neurons. SORLA is best
recognized for its role as a sorting receptor for the amyloid
precursor protein (APP), the main etiologic agent in Alzheimer
disease (AD). SORLA interacts with APP to prevent routing of the
precursor protein into late endosomes where proteolytic break-
down into neurotoxic amyloid-b peptides (Ab) occurs [2,3].
SORLA activity is perceived as neuroprotective as it reduces the
extent of Ab production and senile plaque deposition in mouse
models [4,5] and in patients with sporadic AD [6].
Recently, the relevance of SORLA as a neuroprotective factor
received independent support by findings that Sorl1 (the gene
encoding SORLA) is a downstream target of brain-derived
neurotrophic factor (BDNF), a growth factor that signals through
tropomyosin-related kinase receptor (TrkB) to promote neuronal
survival [7,8]. In neurons, BDNF signaling increases Sorl1
transcription 10-fold whereas absence of BDNF activity in mouse
models with genetic (Bdnf 2/2) or disease-related loss of BDNF in
the brain (Huntington’s disease, HD) results in impaired SORLA
expression and activity [9]. However, the question why SORLA is
part of the trophic response of neurons to BDNF stimulation
remained unanswered.
Using proteomics approaches combined with functional studies
in cultured neurons and in mouse models of HD, we now
identified SORLA as novel sorting factor for TrkB that facilitates
transport of this BDNF receptor along neurites to enhance BDNF
signaling. Thus, BDNF-mediated induction of SORLA expression
may represent a cellular mechanism to potentiate trophic signals, a
pathway potentially disrupted in HD.
Materials and Methods
Ethics Statement
All experiments performed with mice were conducted according
to the guidelines of the German Animal Welfare Law. The study
was approved by the State Office of Health and Social Affairs
Berlin (approval number X9012/12).
Mouse Models, Animal Experimentation and Reagents
Generation of the Huntington’s disease mouse model (B6C3-
Tg(HD82Gln)81Dbo/J) carrying a transgenic huntingtin gene
with 82 CAG repeats [10] and animals genetically deficient for
Sorl12/2 [2] has been described before. For rotarod performance
analysis (adapted from [11]) equal numbers of mice of either
genotype matched for age and sex were analyzed on four
consecutive days for their latency to fall off the accelerating
rotating rod (total n = 8–10; males n = 4–5, females n = 4–5).
Antisera have been obtained from Cell Signaling Technology or
Santa Cruz Biotechnology. Plasmids coding for TrkB-mCherry,
TrkB-EGFP, and SORLA-EGFP have been generated by
introducing corresponding cDNA into the pCI Mammalian
PLOS ONE | www.plosone.org 1 August 2013 | Volume 8 | Issue 8 | e72164
Expression Vector (Promega) and pcDNA3 vector (Invitrogen),
respectively.
Preparation and Treatment of Primary Neurons
Primary cortical neurons were prepared from newborn Balb/c
mice of either sex at postnatal day 1. Cortices were dissociated in
papain (1 hour at 37uC) and cultured on poly-D-lysine/collagen
coated culture dishes. The neurons were cultured for 5 days in
Neurobasal-A medium (Gibco) including B27 supplement (Sigma),
and GlutaMAX (Invitrogen) as previously described [9].
Neurons were treated with BDNF (150 ng/ml, Tebu-Bio) or
medium only (control) for 20 minutes (BDNF/TrkB signaling) or
48 hours (BDNF-dependent proteome changes) by replacing half
of the culture medium with fresh medium. For proteome analyses
the cells were harvested in ice cold PBS and cell pellets were frozen
immediately in liquid nitrogen. Six individual samples of each
treated and control cells were collected (n = 6).
Protein Extraction and 2-D Electrophoresis
For proteome analyses, the cells were harvested in ice cold PBS.
Six individual samples of each treated and control cells were
collected (n = 6). Protein extracts were prepared from frozen cell
pellets and separated by large-gel 2D-PAGE technique as
described [12,13,14]. Protein spot patterns were evaluated using
Delta2D imaging software (version 4.0, Decodon). Percent volume
of spot pixel intensities was used for quantitative analysis of protein
expression by Delta2D as described before [15]. One-way
ANOVA including permutation-based false discovery rate correc-
tion (FDR #10%) was applied to determine statistical significance
of alterations (significance threshold p#0.05; Delta2D). Normal
distribution of data was validated before testing using the
Kolmogorov-Smirnov test (Prism, GraphPad; version 5.0c). Only
fold changes exceeding 20% were considered.
Mass Spectrometry
For protein identification, 1200 mg protein extract was each
separated on a 2-D gel and stained with a MS-compatible silver
staining protocol [12]. Protein spots of interest were excised from
gels and subjected to in-gel tryptic digestion as described [12].
Peptides were characterized by an ESI-tandem-MS/MS on a
LCQ Deca XP ion trap instrument (Thermo Finnigan, Waltham,
MA). Mass spectra were evaluated using MASCOT (version 2.1)
automatically searching SwissProt database (version 51.8/513877
sequences). MS/MS ion search was performed with the following
set of parameters: (i) taxonomy: Mus musculus, (ii) proteolytic
enzyme: trypsin, (iii) maximum of accepted missed cleavages: 1,
(iv) mass value: monoisotopic, (v) peptide mass tolerance 0.8 Da,
(vi) fragment mass tolerance: 0.8 Da, (vii) fixed modifications:
none and (viii) variable modifications: oxidation of methionine and
acrylamide adducts (propionamide) on cysteine. Only proteins
with scores corresponding to p,0.05, with at least two indepen-
dent peptides identified were considered. The cut-off score for
individual peptides was equivalent to p,0.05 for each peptide as
calculated by MASCOT.
Subcellular fractionation studies. Brain tissue was homog-
enized using a glass-Teflon Potter S homogenizer with 10 strokes
at 900 rpm on ice. Homogenates were cleared through differential
centrifugation. Synaptosomes were subjected to osmotic shock and
put on a discontinous sucrose gradient (1.2 M, 1.0 M, 0.8 M).
Further enrichment of different fractions was achieved through
additional steps of centrifugation as described [16,17].
Cell Culture Studies
SH-SY5Y cells [18,19] or primary neurons were transfected
with expression plasmids using Lipofectamine 2000 (Invitrogen).
Co-immunoprecipitation of endogenous proteins from brain
lysates was conducted according to standard protocols utilizing
streptavidin agarose beads (Roche). Surface biotinylation was
carried out using the Cell Surface Protein Isolation Kit (Pierce).
For time-lapse microscopy, primary neurons were transfected the
day after seeding with an expression plasmid encoding EGFP-
tagged human TrkB. The day after transfection, the cells were
imaged on a Zeiss confocal LSM 510 META microscope at 37uC
using a 406 NA 1.2 C-Apochromat objective. Movies were
generated by obtaining images at 1 frame every 2 s for 300 s per
neurite with a 606oil-immersion objective (NA 1.4). A total of 186
(Sorl1+/+) and 228 vesicles (Sorl12/2) in 13–16 neurons per
genotype were analyzed (three independent experiments). Vesicle
movement was quantified by generation of kymostacks using
ImageJ KymoToolbox plugin (http://rsb.info.nih.gov/ij/; avail-
able on request at Fabrice.Cordelieres@curie.fr).
Results
Reduced Proteomic Response in SORLA-deficient
Neurons Following BDNF Treatment
Treatment of primary neurons with BDNF results in a strong
increase in SORLA mRNA and protein levels [9]. To determine
what effect SORLA may have on the trophic response of neurons,
we performed two-dimensional polyacrylamide gel electrophoresis
(2D-PAGE) comparing the proteomic adaptations of primary
neurons either wild type (Sorl1+/+) or genetically deficient for
SORLA (Sorl12/2) to BDNF stimulation. Following the experi-
mental conditions of earlier studies on chronic Sorl1 induction [9],
primary cortical neurons of Sorl1+/+ or Sorl12/2 mice were treated
for 48 hours with 150 ng/ml BDNF or medium only (control).
The global response (Fig. 1A) and the total number of proteins
altered in expression (Fig. 1B) differed markedly between
genotypes. Using mass spectrometry, a number of physiological
BDNF targets were identified that were differentially regulated in
wild type versus SORLA-deficient neurons. These targets included
collapsin response mediator protein-2, eukaryotic elongation
factor 1A, and stathmin (see Table 1 for details).
Reduced Signal Cascade Activation in SORLA-deficient
Neurons after BDNF Treatment
In neurons, BDNF binding to TrkB results in phosphorylation-
dependent activation of TrkB and in down-stream signaling
through the extracellular regulated kinase (ERK) and Akt
pathways [7]. Thus, we analyzed levels of posphorylated (active)
forms of TrkB (pTrkB), as well as of signal mediators ERK (pERK)
and Akt (pAkt) in primary neurons following acute BDNF
application (20 min, 150 ng/ml). Western blot analysis revealed
significant activation of TrkB, ERK, and Akt in both genotypes
after BDNF addition as the phosphorylation of all three proteins
was induced upon stimulation. However, comparing the strength
of signal induction documented markedly reduced activation of all
three signaling cascade components in Sorl12/2 compared with
Sorl1+/+ neurons (Fig. 2A and B). In contrast, the total levels of
TrkB, ERK, and Akt did not vary between genotypes (Fig. 2C and
D).
Taken together, the analysis of signal cascade activation
identified a blunted response to BNDF in neurons lacking SORLA
despite proper expression of TrkB.
SORLA Promotes TrkB Transport and Signaling
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Figure 1. The global BDNF-dependent proteome response is altered in SORLA-deficient neurons. (A) A prototypic two-dimensional
polyacrylamid gel of proteins from Sorl12/2 primary cortical neurons stained with silver nitrate. Significant protein spot alterations in response to
BDNF treatment (150 ng/ml for 2 days) in wild type neurons (red circles), in SORLA-deficient neurons (blue circles) or in both genotypes (green circles)
as compared to untreated samples are indicated. (n = 6 biological replicates per genotype; Student’s t-test p,0.05). (B) Total number of protein spots
altered in primary cortical neurons of the indicated genotypes in response to BNDF treatment as exemplified in panel A. (n = 6 biological replicates
per genotype; Student’s t-test p,0.05).
doi:10.1371/journal.pone.0072164.g001
Table 1. Selected list of proteins differentially regulated in SORLA-deficient versus wild type neurons following chronic BDNF
application.
Protein Sorl12/2 Sorl1+/+ Function
CRMP2 n.a. q 1.96 CRMP2 links TrkB with kinesin-1 to regulate axonal transport of TrkB-containing vesicles [31]. Absent
CRMP2 induction in Sorl12/2 neurons argues for perturbed TrkB trafficking and signaling.
eEF1A n.a. q 1.42 BDNF increases eucaryote elongation factor 1A (eEF1A) phosphorylation to enhance translation
elongation [32]. Reduced eEF1A levels in Sorl12/2 neurons suggests impaired regulation of synaptic
vesicle trafficking.
Stathmin n.a. Q 0.71; 0.73;
0.75; 0.78
Chronic application of BDNF reduces phosphorylation of stathmin [33]. Lack of stathmin suppression in
Sorl12/2 neurons suggests reduced BDNF signaling.
The values indicate ratio of protein spot volume changes (increase q or decrease Q; ANOVA, p,0.05). Where applicable, data for different iso-spots of the same
protein are given. n.a., not altered.
doi:10.1371/journal.pone.0072164.t001
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SORLA Interacts with TrkB and Determins TrkB Surface
Expression
Functional expression of Trk receptors in neurons involves
extensive axonal transport processes whereby these receptor
molecules shuttle between cell body and synapses (reviewed in
[20]). Because SORLA acts as neuronal sorting receptor for APP,
we tested whether the protein may have a similar role in
intracellular transport of TrkB.
Using immunofluorescence microscopy, co-localization of en-
dogenous TrkB and SORLA was shown in primary neurons
(Fig. 3A). Co-immunoprecipitation of endogenous proteins from
brain lysates further documented physical interaction of TrkB with
SORLA (Fig. 3B) (lanes 2 and 3).
To explore the relevance of SORLA activity for TrkB
trafficking, we tested the subcellular localization of the receptor
in the presence or absence of SORLA. Using surface biotinylation
experiments, significantly fewer TrkB molecules were detected at
the surface of neuroblastoma cells expressing SORLA (SY5Y-S)
compared to parental control cells (SY5Y) lacking the protein
(Fig. 3C and D). A shift in subcellular localization of TrkB was also
seen in the murine brain in response to SORLA expression
assubcellular fractionation studies documented increased levels of
TrkB in the synaptic plasma membrane fraction and decreased
levels in the postsynaptic density fraction of mice lacking SORLA
compared with wild-type controls (Fig. 3E and F).
Together, our results demonstrate that SORLA interacts with
TrkB to determine TrkB surface expression. Loss of SORLA
results in accumulation of TrkB at the cell surface. This is in line
with our previous result demonstrating blunted signal cascade
activation as this process depends on internalization and transport
of activated TrkB receptors to intracellular compartments.
SORLA Regulates Anterograde and Retrograde TrkB
Transport
Altered subcellular localization of TrkB and corresponding
changes in TrkB signaling in SORLA-deficient neurons may be
caused by defects in either anterograde, retrograde, or bi-
directional transport of the BDNF receptor. Accordingly, we
applied time-lapse microscopy to measure movement of vesicles
containing a fluorescently labeled fusion protein of TrkB with
EGFP in Sorl1+/+ and Sorl12/2 primary neurons.
Figure 2. Reduced BDNF-dependent activation of TrkB in SORLA-deficient neurons. (A, B) Quantification of phosphorylated (p) forms of
TrkB, Akt, and ERK in primary cortical neurons either non-treated (2) or treated with 150 ng/ml BDNF for 20 min (+) using Western blotting (A) and
densitometric scanning of replicate blots (B). Sorl12/2 neurons show reduced levels of pTrkB, pAKT, and pERK compared with Sorl1+/+ cells (n = 6–12,
Mann-Whitney U test). (C, D) Quantification of total levels of TrkB, Akt, and ERK in primary neurons either non-treated (2) or treated with 150 ng/ml
BDNF (+) for 20 min using Western blot (C) and densitometric scanning of replicate blots (D). Detection of tubulin (tub.) served as loading controls in
A and C.
doi:10.1371/journal.pone.0072164.g002
SORLA Promotes TrkB Transport and Signaling
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As shown in Fig. 4, both anterograde and retrograde trafficking
of TrkB-EGFP containing vesicles was impaired in SORLA-
deficient neurons with a significant reduction in cumulative
distance (Fig. 4B) and speed (Fig. 4C) traveled.
Taken together, analysis of TrkB localization in cells and in the
brain as well as evaluation of TrkB trafficking in transfected
primary neurons argued for a role of SORLA in transport of
TrkB.
SORLA Deficiency Aggravates Disease Phenotype in a
Mouse Model for Huntington' s Disease
In HD, levels of BDNF are distinctly reduced in the striatum of
affected individuals [21,22]. In mouse models of the disease
(HD82 mice; see method for details of the model) [10] reduced
BDNF activity in the striatum coincides with a significant
reduction in expression of the BDNF target SORLA in the very
same brain area to a similar extent [9]. Based on SORLA’s ability
to promote neuritic transport and signaling through TrkB, loss of
SORLA expression in HD may potentiate phenotypes caused by
low BDNF levels. To test this hypothesis, we generated HD82
mice lacking SORLA (HD82xSorl12/2) and compared them to
control HD82 animals (HD82xSorl1+/+).
At 10 weeks of age, HD82xSorl12/2mice displayed pronounced
hind limb clasping compared with HD82 control litter mates
(HD82xSorl1+/+) when suspended by their tail (Fig. 5A). Abnormal
hind limb posture as a consequence of impaired neuromotoric
activity has been observed in HD82 mice before. However, this
phenotype typically does not appear before 16–22 weeks of age
[10]. Worsening of neuromotoric deficits in HD82 mice lacking
SORLA was also substantiated by rotarod performance testing at
10 weeks of age. While HD82 mice showed a significant
improvement in performance when tested for four consecutive
days, HD82xSorl12/2 failed to do so and performed significantly
poorer on day 3 and 4 (Fig. 5B). This phenotype was also seen at
18 weeks of age (Fig. 5C). Neuromotoric deficits were not observed
when comparing Sorl12/2 with wild-type controls (Sorl1+/+)
(Fig. 5D), indicating that behavioral defects in HD82xSorl12/2
mice were caused by aggravation of HD-related phenotypes.
Discussion
Using screening approaches in primary neurons, we previously
identified BDNF as a major inducer of Sorl1 that activates receptor
gene transcription through the ERK pathway. Induction of Sorl1
transcription results in a robust increase in SORLA protein
expression and activity in cultured neurons and in the mouse brain
in vivo [9]. A clue towards understanding the physiological
relevance of SORLA as downstream target of BDNF signaling
came with the proteomics analyses in this study that documented a
blunted response of SORLA-deficient neurons to BDNF applica-
tion (Figs. 1 and 2). The underlying molecular mechanism was
revealed in studies in cultured neurons demonstrating a hitherto
unknown function for SORLA in axonal trafficking of TrkB, a step
critical for efficient neurotrophin signal transduction (Figs. 3 and
4).
To elicit its biological effects, BDNF signals must be conveyed
over long distances from the nerve terminal to the cell body [23].
In detail, nascent TrkB receptor molecules are targeted antero-
gradely along the axonal path to the synapse. Following
neurotrophin binding to Trk receptors, receptor-ligand complexes
internalize in signaling endosomes and signaling persists within
these vesicles as they move retrogradely back to the cell body to
Figure 3. Interaction with SORLA controls trafficking and synaptic exposure of TrkB. (A) Colocalization of endogenous SORLA (red) and
TrkB (green) in primary cortical neurons as shown by confocal immunofluorescence microscopy. Scale bar: 10 mm. (B) Co-immunoprecipitation of
endogenous SORLA and TrkB from brain lysates is seen using anti-SORLA (IP anti-SORLA; lane 2) and anti-Trk antisera (IP anti-TrkB; lane 3). Panel Input
(lane 1) indicates presence of endogenous SORLA and TrkB in brain lysate prior to co-immunoprecipitation. Lane 4 indicates lack co-
immunoprecipitation in the absence of primary antibody (No IgG). (C) SH-SY5Y neuroblastoma cells stably overexpressing SORLA (SY5Y-S) or parental
control cells (SY5Y) were transfected with expression constructs for TrkB. Subsequently, proteins at the cell surface were biotinylated and
immunoprecipitated using streptavidin beads. Western blot analysis documents reduced levels of biotinylated TrkB at the cell surface in SY5Y-S
compared to SY5Y cells (panel Surface). Panel Input represents levels of TrkB and SORLA in cell lysates prior to precipitation. Detection of tubulin
(tub.), b-integrin (b -integ.), and PDGF-b receptor (PDGF-R) served as controls for loading and immunoprecipitation, respectively. (D) Densitometric
quantification of replicate Western blots as exemplified in (C) (n = 6, Student’s t-test). (E) Subcellullar fractionations of wild type and SORLA-deficient
mouse brain extracts were probed for the indicated proteins using Western blot analysis. Elevated levels of TrkB receptors (pan-Trk antibody) are seen
in the synaptosomal plasma membrane (pm) fraction in SORLA-deficient (lanes 7 and 8) as compared to control brains (lanes 5 and 6). In contrast,
levels of Trk receptors in the postsynaptic density (PSD) are reduced in receptor-deficient (lane 10) compared with wild type brains (lane 9). Levels of
Trk in total brain lysates prior to subcellular fractionation are similar between genotypes (lanes 1–4). Detection of synaptophysin (Synapt), AMPA
receptors, and PSD95 served as respective loading controls. (F) Densitometric quantification of replicate Western blots as exemplified in (E) (n = 4–6,
Student’s t-test).
doi:10.1371/journal.pone.0072164.g003
SORLA Promotes TrkB Transport and Signaling
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’
control gene expression [7,24]. The detailed mechanisms of TrkB
transport are not fully resolved. Conceptually, our studies support
a model whereby physical interaction with SORLA facilitates
neuritic transport of TrkB to and from the synapse, promoting
BDNF signal transduction from nerve termini to cell soma. Lack of
SORLA, as in primary Sorl12/2 neurons, results in enhanced
accumulation of TrkB at the synaptic plasma membrane and in
depletion from the post-synaptic density compartment (Fig. 3E
and F). Also, anterograde as well as retrograde transport of TrkB
along neurites is delayed in the absence of the receptor (Fig. 4).
Several cytosolic adaptor proteins, including GGA (Golgi-local-
ized, gamma adaptin ear-containing, ARF-binding protein),
phosphofurin acidic cluster sorting protein 1, and retromer have
been shown to interact with the carboxy-terminal tail of SORLA
and to direct its intracellular trafficking path [3,25]. Potentially,
these interactions not only govern SORLA-dependent transport of
APP but of TrkB as well. Clearly, the molecular mechanisms
controling SORLA-dependent antero/retrograde sorting of TrkB
at the synapse and its relevance for promotion of signal
transduction still await elucidation.
A similar function as for SORLA in trafficking of TrkB has been
documented for sortilin, a related receptor,of the VPS10P domain
receptor family [26]. Unlike sortilin, that mainly regulates
anterograde transport of TrkB, SORLA apparently controls both,
anterograde and retrograde sorting of this receptor. In addition,
Sorl1 but not the gene encoding sortilin is induced by BDNF in
neurons [9]. Thus, SORLA appears as integral part of a self-
potentiating activation loop whereby BDNF distinctly induces
SORLA expression to accelerate axonal transport of its cognate
receptor and to strengthen trophic signals. Further support for the
specificity of this activation loop stems from the fact that BDNF
but not other neurotrophins (such as NGF) induced Sorl1 [9].
BDNF signaling has long been recognized as an autocrine
mechanism whereby adult sensory neurons secrete BDNF to
sustain their own survival signals [27]. A more complicated
scenario is true in the striatum where BDNF produced in cortical
neurons needs to be transported to striatal neurons to support their
survival. Striatal neuronal cell loss due to insufficient BDNF
support has been recognized as a molecular mechanism in HD, a
monogenic disease caused by a polyglutamine expansion (polyQ)
Figure 4. Loss of SORLA impairs vesicular trafficking of TrkB. (A) Movement of TrkB-EGFP in neurites of cultured hippocampal neurons.
Arrows indicate anterograde (red) and retrograde movement (yellow), or no movement (blue) of vesicles. Images were captured every 2 sec. (B) The
cumulative distance travelled by TrkB-EGFP fusion proteins either anterogradely or retrogradely is significantly reduced in Sorl12/2 neurons as
compared to controls (n = 14–16, Student’s t-test). (C) The cumulative anterograde or retrograde speed of the TrkB-EGFP fusion protein is significantly
reduced in Sorl12/2 neurons as compared to Sorl1+/+ cells (n = 14–16, Student’s t-test).
doi:10.1371/journal.pone.0072164.g004
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in huntingtin. Huntingtin is a protein that facilitates vesicular
transport of BDNF along microtubules. Compared to the wild-
type protein, the polyQ-mutated huntingtin fails to efficiently
transport BDNF, resulting in loss of trophic support and in
neuronal toxicity [28]. Experimental evidence suggests that BDNF
arrives in the striatum by anterograde transport from the cortex
via cortico-striatal afferents [29,30]. We have reported before that
in Huntington diseased mice (HD82) low levels of striatal BDNF
result in low levels of SORLA [9]. Now, we show that complete
loss of SORLA expression in HD82 mice aggravates the
neuromotoric decline in this model of HD (Fig. 5). These findings
further support the pathophysiological relevance of impaired
BDNF trophic support in HD, and the relevance of SORLA as
neuronal sorting receptor for TrkB in the molecular pathogenesis
of this disease.
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